| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 10/24/2006 | US7125910 Compounds and compositions for delivering active agents |
| 10/24/2006 | US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 10/24/2006 | US7125892 Aryl aniline β2 adrenergic receptor agonists |
| 10/24/2006 | US7125875 Cyclic protein tyrosine kinase inhibitors |
| 10/24/2006 | US7125871 Excitatory amino acid receptor modulators |
| 10/24/2006 | US7125863 Inhibitors of dipeptidyl peptidase IV |
| 10/24/2006 | US7125442 Lightfast additive having UV-absorbing moiety and ink composition including the same |
| 10/24/2006 | US7125428 1,3-Dihydroxybenzene derivatives and colorants containing said compounds |
| 10/24/2006 | CA2363690C Hsv primase inhibitors |
| 10/24/2006 | CA2262451C Boronic compound complexing reagents and complexes |
| 10/24/2006 | CA2261848C Cell adhesion inhibitors |
| 10/24/2006 | CA2252952C Substituted aminomethylphenylsulphonylureas, their preparation, and their use as herbicides and plant growth regulators |
| 10/24/2006 | CA2208568C Triboluminescent lanthanide iii complexes |
| 10/19/2006 | WO2006110668A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 10/19/2006 | WO2006110477A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 10/19/2006 | WO2006110276A2 Acylated thiosemicarbazides as herbicides |
| 10/19/2006 | WO2006109817A1 1,4-substituted piperazine derivative |
| 10/19/2006 | WO2006109729A1 Pyridylmethylsulfone derivative |
| 10/19/2006 | WO2006086602A3 Improved process for the preparation of 3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine |
| 10/19/2006 | WO2006053082A3 Hydroxybenzoate salts of metanicotine compounds |
| 10/19/2006 | WO2005103041A3 Treatment of cns disorders using cns target modulators |
| 10/19/2006 | WO2005087700A3 Bisphenyl compounds useful as vitamin d3 receptor agonists |
| 10/19/2006 | US20060235229 Reacting 2-substituted pyridine derivatives with nitroalkane in presence of base resulting in 2-nitromethylpyridine derivatives, then hydrogenating in presence of catalysts and acid |
| 10/19/2006 | US20060235223 Variolin derivatives and their use as antitumor agents |
| 10/19/2006 | US20060235220 Dipeptide nitriles |
| 10/19/2006 | US20060235075 Analogous compounds of strobilurines and their use as acaricides and insecticides |
| 10/19/2006 | US20060235073 Diamino-functional chalcones |
| 10/19/2006 | US20060235069 Benzamide modulators of metabotropic glutamate receptors |
| 10/19/2006 | US20060235057 Phenyl compounds |
| 10/19/2006 | US20060235050 Diamine calcium channel blockers |
| 10/19/2006 | US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders |
| 10/19/2006 | US20060235035 Novel methoxybenzamibe compounds for use in mch receptor related disorders |
| 10/19/2006 | US20060235024 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
| 10/19/2006 | US20060235022 Therapeutic agents useful for treating pain |
| 10/19/2006 | US20060235014 Inhibitors of p38 |
| 10/19/2006 | US20060235000 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 10/19/2006 | US20060234927 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 10/19/2006 | US20060234349 Fungal cell wall synthesis gene |
| 10/19/2006 | US20060234283 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity |
| 10/19/2006 | CA2604291A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 10/19/2006 | CA2603701A1 1,4-substituted piperazine derivative |
| 10/19/2006 | CA2603320A1 Pyridylmethylsulfone derivative |
| 10/18/2006 | EP1712242A1 Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |
| 10/18/2006 | EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds |
| 10/18/2006 | EP1711461A2 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 10/18/2006 | EP1711175A1 Diurea derivatives |
| 10/18/2006 | EP1414830B1 Tumour inhibiting lanthane compounds |
| 10/18/2006 | EP1414829B1 Tumour inhibiting cerium compounds |
| 10/18/2006 | EP1283828B1 Novel polymorph v of torasemide |
| 10/18/2006 | EP1027397B1 Electrochrome polymer systems |
| 10/18/2006 | CN1847253A Process for preparing amine platinum complexes |
| 10/18/2006 | CN1280672C Photosensitive compound, resin and composition |
| 10/18/2006 | CN1280293C Improved method for making nevirapine |
| 10/18/2006 | CN1280274C Supernucleophilic 4-substituted-pyridine catalysts |
| 10/18/2006 | CN1280273C Synthesis of donepizin and its derivative |
| 10/18/2006 | CN1280267C Sulfonylaminocarboxylic acids |
| 10/18/2006 | CN1280259C Aryl aniline beta-2 adrenergic receptor agonists |
| 10/17/2006 | US7122711 Method for producing biaryl compound |
| 10/17/2006 | US7122643 Cytostatic lanthanum compounds |
| 10/17/2006 | US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 10/17/2006 | US7122563 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 10/17/2006 | US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents |
| 10/17/2006 | US7122556 Phenylalanine enamide derivatives |
| 10/17/2006 | US7122551 Metalloproteinase inhibitor compounds |
| 10/17/2006 | US7122547 Anthranilic acid amides and the use thereof as medicaments |
| 10/17/2006 | US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action |
| 10/17/2006 | US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 10/17/2006 | US7122536 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
| 10/17/2006 | US7121707 Illuminated electrical cords and outlets |
| 10/17/2006 | CA2318527C Inhibitors of .alpha.4 mediated cell adhesion |
| 10/12/2006 | WO2006106984A1 Potentiator for radiation therapy comprising pyridine derivative as active ingredient |
| 10/12/2006 | WO2006106778A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | WO2006106727A1 Benzyloxypropylamine derivative |
| 10/12/2006 | WO2006106423A2 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| 10/12/2006 | WO2006106054A1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 10/12/2006 | WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 10/12/2006 | WO2005095326A8 2-amino- and 2-thio-substituted 1,3-diaminopropanes |
| 10/12/2006 | US20060229470 Calcium receptor-active molecules |
| 10/12/2006 | US20060229457 Method for producing optically active compound |
| 10/12/2006 | US20060229363 Substituted Heteroaryl- and Phenylsulfamoyl Compounds |
| 10/12/2006 | US20060229342 TNF-a production inhibitors |
| 10/12/2006 | US20060229341 Peptide deformylase inhibitors |
| 10/12/2006 | US20060229338 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 10/12/2006 | US20060229326 For therapy and prophylaxis of diseases which are associated with the modulation of cannabinoid receptors (CB1), such as obesity |
| 10/12/2006 | US20060229304 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
| 10/12/2006 | US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 10/12/2006 | US20060229281 Cycloalkyl-Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses |
| 10/12/2006 | US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
| 10/12/2006 | US20060229206 For controlling undesirable plants; 1-[3-(3-Chlorobenzamido)-benzoyl]-4-(2-chlorophenyl)-thiosemicarbazide |
| 10/12/2006 | US20060228752 Genetic polymorphisms in the preprotachykinin gene |
| 10/12/2006 | US20060226766 Electroluminescent device |
| 10/12/2006 | CA2603030A1 Benzyloxypropylamine derivative |
| 10/12/2006 | CA2602787A1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 10/12/2006 | CA2602467A1 Bcrp/abcg2 inhibitor |
| 10/11/2006 | EP1710240A1 Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists |
| 10/11/2006 | EP1710238A1 Benzophenones as inhibitors of reverse transcriptase |
| 10/11/2006 | EP1710236A1 Derivatives of pyridine and quinoline |
| 10/11/2006 | EP1710231A1 CETP activity inhibitors |
| 10/11/2006 | EP1709037A2 Hiv protease inhibiting sulfonamides |
| 10/11/2006 | EP1709017A1 Urea derivatives |